What 2020 means for the life sciences
Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.
- Pricing, patents and the PMPRB in Canada 14-12-2020
- The doctrine of equivalents in the medtech arena 18-11-2020
- Why Santen ends Neurim-style SPCs 25-08-2020
- The right recipe for the repurposing omelette 14-08-2020
- No SPC crown for Royalty Pharma 10-07-2020
Latest big pharma news
Pfizer sues India generic drugmaker over cancer drug
14-01-2021
Pharmaceutical company Pfizer has accused generic drug maker Aurobindo of infringement, as it attempts to block the roll-out of copies of its blockbuster arthritis drug, Xeljanz.
